AKT1 and cancer: For malignant cells, the targets were significantly enriched in critical cancer pathways, including “MicroRNAs in cancer,” “PI3K-Akt signaling pathway,” and “FoxO signaling pathway,” confirming that our predictions capture biologically coherent regulatory modules.